Both in Pharmaceuticals
Skye Bioscience vs Bolt Biotherapeutics
Over the past year SKYE returned −94.9% and BOLT returned −31.6%; their daily moves had a correlation of 0.15.
SKYE −94.9% BOLT −31.6%Growth of $1, one year, split-adjusted
| Metric | SKYE | BOLT |
|---|---|---|
| Price | $1.59 | $3.60 |
| Market cap | $7.0M | $6.9M |
| Today | −1.24% | +4.04% |
| 1 month | −10.4% | −5.6% |
| 6 months | −66.5% | −15.3% |
| Year to date | −73.5% | −34.2% |
| 1 year | −95.2% | −33.6% |
| Revenue growth (YoY) | — | −99.7% |
| Gross margin | — | 100.0% |
| Net margin | — | −154400.0% |
| P/E (TTM) | — | — |
| Price / sales | — | 1.5× |
| Net cash | $9.9M | $17.6M |
| Dividend yield | — | — |
| Volatility (60d) | 616.5% | 73.0% |
| Short % of float | 0.5% | 1.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).